Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry

[1]  I. Anand.  Cardiorenal syndrome: a cardiologist's perspective of pathophysiology. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[2]  S. Lipshultz,et al.  Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure , 2013, Pediatric Nephrology.

[3]  J. Kellum,et al.  Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). , 2013, Contributions to nephrology.

[4]  S. Goldstein,et al.  Cardorenal syndrome: an emerging problem in pediatric critical care , 2013, Pediatric nephrology (Berlin, West).

[5]  S. Goldstein,et al.  Erratum to: Cardiorenal syndrome: an emerging problem in pediatric critical care , 2013, Pediatric Nephrology.

[6]  R. Goldschmeding,et al.  Target organ cross talk in cardiorenal syndrome: animal models. , 2012, American journal of physiology. Renal physiology.

[7]  S. Lipshultz,et al.  Why multidisciplinary clinics should be the standard for treating chronic kidney disease , 2012, Pediatric Nephrology.

[8]  C. Fraser,et al.  Congenital heart surgery in infants: effects of acute kidney injury on outcomes. , 2012, The Journal of thoracic and cardiovascular surgery.

[9]  A. Mebazaa,et al.  Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. , 2012, Seminars in nephrology.

[10]  S. Goldstein,et al.  Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. , 2011, Journal of the American College of Cardiology.

[11]  M. Balogun,et al.  The significance of mild renal dysfunction in chronic heart failure. , 2011, West African journal of medicine.

[12]  L. Tavazzi,et al.  Clinical outcome of renal tubular damage in chronic heart failure. , 2011, European heart journal.

[13]  M. Mack,et al.  Kidney injury molecule‐1 and N‐acetyl‐ß‐d‐glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome , 2011, European journal of heart failure.

[14]  C. Ronco,et al.  The Cardiorenal Syndrome , 2011, International journal of nephrology.

[15]  S. Furth,et al.  Pediatric GFR estimating equations applied to adolescents in the general population. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[16]  C. Canter,et al.  Dilated cardiomyopathy and heart failure in children. , 2010, Heart failure clinics.

[17]  Dylan L. Steen,et al.  Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population , 2010, European journal of heart failure.

[18]  M. Burnier,et al.  Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  P. Ponikowski,et al.  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[20]  G. Schwartz,et al.  Measurement and estimation of GFR in children and adolescents. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[21]  Susan L Furth,et al.  New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[22]  Rinaldo Bellomo,et al.  Cardiorenal syndrome. , 2008, Journal of the American College of Cardiology.

[23]  J. Towbin,et al.  Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome?* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[24]  F. Grenier,et al.  Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[25]  V. Hasselblad,et al.  Cardiorenal interactions: insights from the ESCAPE trial. , 2008, Journal of the American College of Cardiology.

[26]  S. Colan,et al.  Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.

[27]  P. Palatini,et al.  Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. , 2006, Kidney international.

[28]  Peter C Austin,et al.  Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.

[29]  A. Rigby,et al.  Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. , 2006, European heart journal.

[30]  Hans L. Hillege,et al.  Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.

[31]  T. Berl,et al.  Kidney-heart interactions: epidemiology, pathogenesis, and treatment. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[32]  Karl Swedberg,et al.  Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. , 2004, European heart journal.

[33]  W. Hörl,et al.  A critical appraisal for definition of hyperfiltration. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  M. Nieminen,et al.  [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. , 2004, Revista espanola de cardiologia.

[35]  Hsueh-Wen Chang,et al.  Risk Stratification of In-Hospital Mortality in Patients Hospitalized for Chronic Congestive Heart Failure Secondary to Non-Ischemic Cardiomyopathy , 2003, Cardiology.

[36]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[37]  Kevin V Lemley,et al.  National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. , 2003, Pediatrics.

[38]  E John Orav,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[39]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  E J Orav,et al.  Design and implementation of the North American Pediatric Cardiomyopathy Registry. , 2000, American heart journal.

[42]  C. Price,et al.  Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children , 2000, Archives of disease in childhood.

[43]  L Ryan,et al.  Survival analysis in natural history studies of disease. , 1989, Statistics in medicine.

[44]  J. Laragh,et al.  Regulation of glomerular filtration rate in chronic congestive heart failure patients. , 1988, Kidney international.